Ascendis Pharma A/S vs IQIYI Inc - ADR — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while IQIYI Inc - ADR trades at $1.34 (market cap $1.30B). The key difference: Ascendis Pharma A/S is far larger — about 12.8× IQIYI Inc - ADR's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals.
| ASND | IQ | |
|---|---|---|
Market Cap | $16.67B | $1.30B |
Sector | Health | Media |
52-Week High | $277.18 | $2.79 |
52-Week Low | $189.74 | $0.96 |
Enterprise Value | $17.04B | $2.88B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →